New Metabolic Disease Articles from our Partners at Consultant 360

New Study Challenges Antihypertensive Guidance

The results of a recent study challenge current recommendations for first-line hypertension therapies.

https://www.consultant360.com/exclusive/consultant360/primary-care/new-study-challenges-antihypertensive-guidance

Lowering Dietary Sodium Intake Has Dose-Response Effect on BP

Prior short-term studies may have underestimated the effects of reduced dietary sodium intake on blood pressure, according to a new systematic review and meta-analysis of 133 studies that had included more than 12,000 individuals.

https://www.consultant360.com/consultant360/primary-care/lowering-dietary-sodium-intake-has-dose-response-effect-bp

Statins May Increase the Risk of Diabetes in High-Risk Patients

The association between statins and diabetes mellitus is controversial. To better understand the connection, investigators of the KP CHAMP study analyzed the risk of incident diabetes mellitus among individuals at risk for ASCVD who initiated statins. Here is what they found.

https://www.consultant360.com/exclusive/cardiology/cardiometabolic-risk/statins-may-increase-risk-diabetes-high-risk-patients

Higher BP Variability Affects AFib Risk

Authors of a new study analyzed data on more than 8 million patients to better understand the association between blood pressure variability and atrial fibrillation risk. Do you think hypertension affected the association? Read the full story to find out.

https://www.consultant360.com/exclusive/cardiology/arrhythmia-ep/higher-bp-variability-affects-afib-risk

Among Women With Preeclampsia, CV Mortality Risk Quadruples in the Long Term

How does preeclampsia affect women’s 15-year risk of myocardial infarction, stroke, cardiovascular mortality, and all-cause mortality? Researchers recently investigated, and their findings might surprise you.

https://www.consultant360.com/exclusive/cardiology/hypertension/among-women-preeclampsia-cv-mortality-risk-quadruples-long-term